Cargando…
Tumor-Specific T Cell Activation in Malignant Brain Tumors
Due to their delicate locations as well as aggressive and infiltrative behavior, malignant brain tumors remain a therapeutic challenge. Harnessing the efficacy and specificity of the T-cell response to counteract malignant brain tumor progression and recurrence, represents an attractive treatment op...
Autores principales: | Mohme, Malte, Neidert, Marian Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031483/ https://www.ncbi.nlm.nih.gov/pubmed/32117316 http://dx.doi.org/10.3389/fimmu.2020.00205 |
Ejemplares similares
-
Targeting Malignant Brain Tumors with Antibodies
por: Razpotnik, Rok, et al.
Publicado: (2017) -
Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells
por: Schluck, Marjolein, et al.
Publicado: (2019) -
Harnessing type I interferon-mediated immunity to target malignant brain tumors
por: Lim, Juhee, et al.
Publicado: (2023) -
T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
por: Janelle, Valérie, et al.
Publicado: (2020) -
Distinct topographic-anatomical patterns in primary and secondary brain tumors and their therapeutic potential
por: Akeret, Kevin, et al.
Publicado: (2020)